<?xml version="1.0" encoding="utf-8" standalone="yes" ?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Xiao Shuai | CC LY LAB</title>
    <link>https://pangxueyu233.github.io/author/xiao-shuai/</link>
      <atom:link href="https://pangxueyu233.github.io/author/xiao-shuai/index.xml" rel="self" type="application/rss+xml" />
    <description>Xiao Shuai</description>
    <generator>Source Themes Academic (https://sourcethemes.com/academic/)</generator><language>en-us</language><lastBuildDate>Sun, 01 Mar 2020 00:00:00 +0000</lastBuildDate>
    <image>
      <url>https://pangxueyu233.github.io/images/icon_hu0b7a4cb9992c9ac0e91bd28ffd38dd00_9727_512x512_fill_lanczos_center_2.png</url>
      <title>Xiao Shuai</title>
      <link>https://pangxueyu233.github.io/author/xiao-shuai/</link>
    </image>
    
    <item>
      <title>Nivolumab treatment of relapsed/refractory Epstein-Barr virusâ€“associated hemophagocytic lymphohistiocytosis in adults</title>
      <link>https://pangxueyu233.github.io/publication/2020_blood_paper/</link>
      <pubDate>Sun, 01 Mar 2020 00:00:00 +0000</pubDate>
      <guid>https://pangxueyu233.github.io/publication/2020_blood_paper/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Epigenetic drug library screening identified an LSD1 inhibitor to target UTX-deficient cells for differentiation therapy</title>
      <link>https://pangxueyu233.github.io/publication/2019_sttd_paper/</link>
      <pubDate>Mon, 01 Apr 2019 00:00:00 +0000</pubDate>
      <guid>https://pangxueyu233.github.io/publication/2019_sttd_paper/</guid>
      <description></description>
    </item>
    
  </channel>
</rss>
